Skip to content
HowShorted

OPKO Health, Inc. short interest in 2025

In 2025, OPKO Health, Inc.'s disclosed short interest ran from 12.88% of shares outstanding on 15 Jan 2025 to 3.95% on 31 Dec 2025, a change of -8.93 percentage points. The year's high was 17.35% on 31 Mar 2025 and its low 3.91% on 13 Jun 2025, averaging 6.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 43.66 days on 31 Jan 2025. Full history: OPKO Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OPKO Health, Inc. in 2025

2025 in figures

Start of year
12.88% (15 Jan 2025)
End of year
3.95% (31 Dec 2025)
Change
-8.93 pp
High
17.35% (31 Mar 2025)
Low
3.91% (13 Jun 2025)
Average
6.74%
Highest days to cover
43.66 (31 Jan 2025)
SEC filings marked
8

Every report in 2025

OPKO Health, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202512.88%28.86
31 Jan 202513.20%43.66
14 Feb 202513.20%27.19
28 Feb 202513.32%19.48results (8-K)
14 Mar 202516.53%9.0510-K filed
31 Mar 202517.35%34.36
15 Apr 20254.41%7.82
30 Apr 20254.40%14.10results (8-K)
15 May 20254.29%7.8110-Q filed
30 May 20253.99%12.08
13 Jun 20253.91%12.34
30 Jun 20254.30%7.30
15 Jul 20254.09%15.89
31 Jul 20254.13%11.7310-Q filed, results (8-K)
15 Aug 20254.16%10.50
29 Aug 20254.09%16.63
15 Sep 20254.14%16.73
30 Sep 20254.24%10.54
15 Oct 20254.20%20.27
31 Oct 20254.27%17.9410-Q filed, results (8-K)
14 Nov 20254.40%12.43
28 Nov 20254.09%10.96
15 Dec 20254.24%10.82
31 Dec 20253.95%7.16

See also: OPKO Health, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.